biosimilars in the us and beyond
Published 7 years ago • 308 plays • Length 11:03Download video MP4
Download video MP3
Similar videos
-
21:21
beyond reference biologics: biosimilars on the horizon
-
14:19
regulatory pathway for biosimilars
-
16:48
biosimilars in ibd: where do we stand today?
-
4:12
the basics of biosimilars
-
38:15
biosimilars and biologics
-
15:01
euronews debates highlights | how can europe shape the future of biosimilar medicines?
-
1:45
what is a biosimilar? - video explainer
-
6:07
manufacturing of biologics
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
16:47
what is needed and what is the role of biosimilars?
-
3:33
biosimilars: manufacturing and inherent variation
-
16:44
the current landscape of biosimilars in ibd
-
7:21
biologic drugs and biosimilars
-
5:20
data requirements for biosimilars
-
0:41
similarity of biosimilars and biologics
-
39:48
optimizing biosimilars for safe and effective management of imids
-
53:18
utilization of biosimilars: achieving value-based plan management
-
4:41
biologics, unbranded biologics, and biosimilars - what is the difference?
-
1:48
dr. markman on the concept of biosimilars in oncology
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
2:04
biosimilars: the path to approval
-
51:57
pinpointing the top questions and considerations about biosimilars in gastroenterology